SCHEMBL4731813

SCHEMBL4731813

COCCN(C(=O)c1ccc(Cl)cc1Cl)c1ccsc1C(=O)OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ POLB P06746 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ KMT2A Q03164 5/20 0.42
▸ CRHR1 P34998 1/20 0.39
▸ FLT1 P17948 1/20 0.39
▸ FLT4 P35916 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4731581 0.84 CYP3A4 (0.43) CYP3A4RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL1961753 0.79 CYP3A4 (0.38) CYP3A4RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL4159892 0.79 MAPT (0.45) CYP3A4RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL12578110 0.75 CYP3A4 (0.42) CYP3A4RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL4729550 0.74 NPC1 (0.38) CYP3A4RAB9AMAPTNPC1POLB
SCHEMBL14223408 0.73 KMT2A (0.68) CYP3A4RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL1960198 0.72 CACNA2D1 (0.45) CYP3A4RAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL1958427 0.72 CYP2E1 (0.41) CYP3A4SMN1; SMN2ALDH1A1KMT2ACRHR1
SCHEMBL2432527 0.71 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1POLBCYP1A2NPSR1
SCHEMBL669399 0.71 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1POLBCYP1A2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008043791-A2 THIOPHENE DERIVATIVES FOR TREATING HEPATITIS C SMITHKLINE BEECHAM CORPORATION (US) 2008-04-17 — — WO disclosed
WO-2008043791-A2 THIOPHENE DERIVATIVES FOR TREATING HEPATITIS C SMITHKLINE BEECHAM CORPORATION (US) 2008-04-17 — — WO disclosed
Send feedback